Clinical success in anti-cancer immunotherapy involving checkpoint modulation, chimeric antigen receptor T-cell therapy, and bispecific T-cell engagers is a key factor behind the rapid growth of biologics. While these approaches employ different functional tactics to attack tumors, they all utilize monoclonal antibody-based binding molecules to target specific antigens.
This eBook highlights articles that provide useful insights into current antibody screening tools and how they can help researchers developing novel biologics.
Featured Articles
Complete the form to download
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Shop Sartorius Products Now